Dawson Private Markets Evergreen Fund has reported a change in its management structure with the filing of a Form 3, which indicates the appointment of Owen Andrew as a new trustee. This update is significant as it may reflect strategic adjustments within the fund and could impact its operational direction.
The Dawson Private Markets Evergreen Fund is a private equity firm based in New York, incorporated in Delaware. The fund focuses on investments in private markets, aligning with the growing interest in alternative investment strategies. The recent filing, dated November 4, 2026, is part of a series of disclosures made by the fund, which include several Form 3 submissions on the same day.
According to the filing, Owen Andrew is identified as a trustee, although he is not listed as a director or officer. This designation indicates a role that may involve oversight and governance responsibilities without direct operational management. The filing notes, "Exhibit 24 - Power of Attorney," which suggests that Andrew has been granted authority to act on behalf of the fund in certain legal and administrative matters.
This change may affect the fund's stakeholders, including investors and partners, as governance structures often influence decision-making processes and strategic initiatives. The involvement of a trustee can bring new perspectives and potentially alter the fund's investment strategies or operational focus.
Details were not available in the SEC filing regarding the next steps following this appointment. The filing does not specify any upcoming votes or additional filings related to this change.
Read Next
Recursion Pharmaceuticals reports change in ownership
Fowler Todd C. reports stock transaction in Saia Inc.
Recursion Pharmaceuticals grants restricted stock units to director
Borgeson Blake Sells 40,000 Shares of Recursion Pharmaceuticals
CB Financial Services reports key stock transactions by COO
Stride, Inc. Director Reports Significant Stock Purchases




